These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

527 related articles for article (PubMed ID: 9047374)

  • 1. Binding of amino acid side-chains to S1 cavities of serine proteinases.
    Lu W; Apostol I; Qasim MA; Warne N; Wynn R; Zhang WL; Anderson S; Chiang YW; Ogin E; Rothberg I; Ryan K; Laskowski M
    J Mol Biol; 1997 Feb; 266(2):441-61. PubMed ID: 9047374
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Binding of amino acid side chains to preformed cavities: interaction of serine proteinases with turkey ovomucoid third domains with coded and noncoded P1 residues.
    Bigler TL; Lu W; Park SJ; Tashiro M; Wieczorek M; Wynn R; Laskowski M
    Protein Sci; 1993 May; 2(5):786-99. PubMed ID: 8495199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thermodynamic criterion for the conformation of P1 residues of substrates and of inhibitors in complexes with serine proteinases.
    Qasim MA; Lu SM; Ding J; Bateman KS; James MN; Anderson S; Song J; Markley JL; Ganz PJ; Saunders CW; Laskowski M
    Biochemistry; 1999 Jun; 38(22):7142-50. PubMed ID: 10353824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interscaffolding additivity. Association of P1 variants of eglin c and of turkey ovomucoid third domain with serine proteinases.
    Qasim MA; Ganz PJ; Saunders CW; Bateman KS; James MN; Laskowski M
    Biochemistry; 1997 Feb; 36(7):1598-607. PubMed ID: 9048543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contribution of peptide bonds to inhibitor-protease binding: crystal structures of the turkey ovomucoid third domain backbone variants OMTKY3-Pro18I and OMTKY3-psi[COO]-Leu18I in complex with Streptomyces griseus proteinase B (SGPB) and the structure of the free inhibitor, OMTKY-3-psi[CH2NH2+]-Asp19I.
    Bateman KS; Huang K; Anderson S; Lu W; Qasim MA; Laskowski M; James MN
    J Mol Biol; 2001 Jan; 305(4):839-49. PubMed ID: 11162096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Despite having a common P1 Leu, eglin C inhibits alpha-lytic proteinase a million-fold more strongly than does turkey ovomucoid third domain.
    Qasim MA; Van Etten RL; Yeh T; Saunders C; Ganz PJ; Qasim S; Wang L; Laskowski M
    Biochemistry; 2006 Sep; 45(38):11342-8. PubMed ID: 16981694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Water molecules participate in proteinase-inhibitor interactions: crystal structures of Leu18, Ala18, and Gly18 variants of turkey ovomucoid inhibitor third domain complexed with Streptomyces griseus proteinase B.
    Huang K; Lu W; Anderson S; Laskowski M; James MN
    Protein Sci; 1995 Oct; 4(10):1985-97. PubMed ID: 8535235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Affinity and specificity of serine endopeptidase-protein inhibitor interactions. Empirical free energy calculations based on X-ray crystallographic structures.
    Krystek S; Stouch T; Novotny J
    J Mol Biol; 1993 Dec; 234(3):661-79. PubMed ID: 8254666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure-function relationship of serine protease-protein inhibitor interaction.
    Otlewski J; Jaskólski M; Buczek O; Cierpicki T; Czapińska H; Krowarsch D; Smalas AO; Stachowiak D; Szpineta A; Dadlez M
    Acta Biochim Pol; 2001; 48(2):419-28. PubMed ID: 11732612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crystal structures of five bovine chymotrypsin complexes with P1 BPTI variants.
    Czapinska H; Helland R; Smalås AO; Otlewski J
    J Mol Biol; 2004 Dec; 344(4):1005-20. PubMed ID: 15544809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Binding pockets on the surface of human leukocyte elastase and human leukocyte cathepsin G. Implications to the design of inhibitors derived from human C-reactive protein.
    Yavin EJ; Eisenstein M; Fridkin M
    Biomed Pept Proteins Nucleic Acids; 1996-1997; 2(3):71-8. PubMed ID: 9575343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Probing intermolecular main chain hydrogen bonding in serine proteinase-protein inhibitor complexes: chemical synthesis of backbone-engineered turkey ovomucoid third domain.
    Lu W; Qasim MA; Laskowski M; Kent SB
    Biochemistry; 1997 Jan; 36(4):673-9. PubMed ID: 9020764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Variability of the canonical loop conformations in serine proteinases inhibitors and other proteins.
    Apostoluk W; Otlewski J
    Proteins; 1998 Sep; 32(4):459-74. PubMed ID: 9726416
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NMR determination of pKa values for Asp, Glu, His, and Lys mutants at each variable contiguous enzyme-inhibitor contact position of the turkey ovomucoid third domain.
    Song J; Laskowski M; Qasim MA; Markley JL
    Biochemistry; 2003 Mar; 42(10):2847-56. PubMed ID: 12627950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The crystal structure of PR3, a neutrophil serine proteinase antigen of Wegener's granulomatosis antibodies.
    Fujinaga M; Chernaia MM; Halenbeck R; Koths K; James MN
    J Mol Biol; 1996 Aug; 261(2):267-78. PubMed ID: 8757293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predicting proteinase specificities from free energy calculations.
    Mekonnen SM; Olufsen M; Smalås AO; Brandsdal BO
    J Mol Graph Model; 2006 Oct; 25(2):176-85. PubMed ID: 16386933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two conformational states of Turkey ovomucoid third domain at low pH: three-dimensional structures, internal dynamics, and interconversion kinetics and thermodynamics.
    Song J; Laskowski M; Qasim MA; Markley JL
    Biochemistry; 2003 Jun; 42(21):6380-91. PubMed ID: 12767219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ionizable P1 residues in serine proteinase inhibitors undergo large pK shifts on complex formation.
    Abul Qasim M; Ranjbar MR; Wynn R; Anderson S; Laskowski M
    J Biol Chem; 1995 Nov; 270(46):27419-22. PubMed ID: 7499197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural and functional study of an Anemonia elastase inhibitor, a "nonclassical" Kazal-type inhibitor from Anemonia sulcata.
    Hemmi H; Kumazaki T; Yoshizawa-Kumagaye K; Nishiuchi Y; Yoshida T; Ohkubo T; Kobayashi Y
    Biochemistry; 2005 Jul; 44(28):9626-36. PubMed ID: 16008348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interscaffolding additivity: binding of P1 variants of bovine pancreatic trypsin inhibitor to four serine proteases.
    Krowarsch D; Dadlez M; Buczek O; Krokoszynska I; Smalas AO; Otlewski J
    J Mol Biol; 1999 May; 289(1):175-86. PubMed ID: 10339415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.